-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Rheumatoid Arthritis Drug Details: Lu-AG22515 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Systemic Lupus Erythematosus Drug Details: Lu-AG22515 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Neuromyelitis Optica (Devic’s Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Neuromyelitis Optica (Devic's Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Neuromyelitis Optica (Devic's Syndrome) Drug Details: Lu-AG22515 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ludotadipep in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ludotadipep in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ludotadipep in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
Shanxi Lu Guang Power Plant
Shanxi Lu Guang Power Plant is a thermal project located in Shanxi, China. The project is owned by Anhui Wenergy Co Ltd; Banpu Power Investment (China) Ltd.; Gemeng International Energy Co Ltd and was developed by Shanxi Luguang Power Co Ltd. The project came online in 2021. Empower your strategies with our Shanxi Lu Guang Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
Henan Lu Yi Feng Shang I
Henan Lu Yi Feng Shang I is an Onshore Wind project located in Henan, China. The project is owned by China General Nuclear Power Corp Ltd; Sembcorp Industries Ltd and was developed by China General Nuclear Power Corp Ltd. The project came online in 2020. Empower your strategies with our Henan Lu Yi Feng Shang I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sucunamostat in Proteinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sucunamostat in Proteinuria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sucunamostat in Proteinuria Drug Details: Sucunamostat (SCO-792) is under development for the treatment...